 |
|
| Blog results | Results 1 - 10 of about 5,837 for raloxifene estrogen. (0.33 seconds) |
| Sorted by relevance Sort by date |
| 22 hours ago by admin Similarto estrogen, raloxifene should be discontinued at least 72 h before and during prolonged immobilization (surgery recovery, prolonged bed rest). Women taking raloxifene should also be advised to avoid prolonged restriction of ... No SubHealth - http://www.nosubhealth.com/ |
| 24 Oct 2009 by rspike I was wondering if anyone has used evista - raloxifene to combat estrogen sides and how is it when compared to others like Nolva? MESO-Rx - http://forum.mesomorphosis.com/ |
| 19 Nov 2009 by Nelson HD, Fu R, Griffin JC, Nygren P,... Tamoxifen and raloxifene reduce estrogen receptor-positive breast cancer but not estrogen receptor-negative breast cancer, noninvasive breast cancer, or mortality. All medications reduce fractures. Tamoxifen (risk ratio, 1.93 [CI, ... JournalFeeds - http://journalfeeds.com/ |
| 16 Nov 2009 by salud equitativa Selective estrogen receptor modulators (SERMs), specifically raloxifene and tamoxifen. Testosterone for men. Vitamin D. Combinations of above. Exercise in comparison to above agents. Key Question 2. How does fracture reduction resulting ... CIENCIASMEDICASNEWS - http://elbiruniblogspotcom.blogspot.com/ - References [ More results from CIENCIASMEDICASNEWS ] |
| 13 Nov 2009 by Margaret Polaneczky, MD (aka TBTAM) For the record, I inform each and very patient who starts estrogen containing birth control that there is an increased risks of clots. I quantify it for them, tell them that it is a real risk and give them strategies they can use to ... The Blog that Ate Manhattan - http://theblogthatatemanhattan.blogspot.com/ - References |
| 16 Nov 2009 by David Gorski Tamoxifen is a selective estrogen receptor modulator (SERM) that antagonizes estrogen action in breast tissues but has partial agonist activity in bone and endometrium. Indeed, raloxifene, another SERM, is used primarily to prevent and ... Science-Based Medicine - http://www.sciencebasedmedicine.org/ - References |
| 14 Nov 2009 Raloxifene, brand name is Evista osteoporosis drug can increase bone density. Raloxifene or raloxifene is a SERM – selective estrogen to accept modification, not only improves bone density, but also can lower cholesterol. ... Arthritis Neck Pain - http://www.arthritisneckpain.org/ |
| 29 Oct 2009 by Legault, Maki, Resnick, Coker, Hogan, Bevers,... Purpose To compare the effects of two selective estrogen receptor modulators, tamoxifen and raloxifene, on global and domain-specific cognitive function. Patients and Methods The National Surgical Adjuvant Breast and Bowel Project's ... Journal of Clinical Oncology Current Issue - http://jco.ascopubs.org/ [ More results from Journal of Clinical Oncology Current Issue ] |
| 9 Nov 2009 Both drugs prevent estrogen from working in cells. Fulvestrant is marketed for women as Faslodex, and raloxifene is marketed as Evista. The study appears in this week's issue of the Proceedings of the National Academy of Sciences. ... myOptumHealth - http://www.myoptumhealth.com/portal/ |
| 9 Nov 2009 "Since the cervix and other female reproductive organs are so responsive to estrogen, our lab and others began to focus on that hormone," he explained. Fulvestrant and raloxifene block a receptor (estrogen receptor alpha) that mediates ... Drugs.com - Daily MedNews - http://www.drugs.com/medical-news.html |
Stay up to date on these results:
| Google Home - About Google Blog Search Beta - Information for Blog Authors |
